CLINICAL_TRIALS
trial_result
· 2008-03-04
Clinical Trial Update: New Cysteamine Eye Drops Formulation to Treat Corneal Crystals in Cystinosis [Phase 1]
Summary
Phase 1 trial evaluating a new cysteamine eye drop formulation to treat corneal crystals in cystinosis completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Eye Institute (NEI) | Conditions: Cystinosis | Phase 1 | Status: COMPLETED